Relapsing pancreatitis due to a novel compound heterozygosity in the CFTR gene involving the second most common mutation in Central and Eastern Europe [CFTRdele2,3(21 kb)]

Pancreatology

Volumn 5, Issue 1, 2005, Pages 92-96

  Lamprecht, Georg ^a   Mau, Ulrike A ^a   Kortüm, Christian ^a   Raible, Armin ^a   Stern, Martin ^a   Rieß, Olaf ^a   Gregor, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cationic pancreatic trypsinogen; CFTR compound heterozygosity; CFTRdele2,3(21 kb); Idiopathic pancreatitis; Pancreatic secretory trypsinogen inhibitor; PRSS1; R117H; SPINK1

Indexed keywords

AMYLASE; CALCIUM; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEMOGLOBIN DETERMINATION; HETEROZYGOSITY; HORMONE DETERMINATION; HOSPITAL ADMISSION; HUMAN; INTRON; LABORATORY TEST; LEUKOCYTE COUNT; PANCREATITIS; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSE; THROMBOCYTE COUNT; TRANSMEMBRANE CONDUCTANCE REGULATOR GENE;

EID: 18744415460     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000084495     Document Type: Article

References (17)

1. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LKJ, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145.
2. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-216.
3. Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-623.
4. Drenth JPH, Te M, Jansen JBMJ: Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002;50:687-692.
5. Cohn JA, Bornstein JD, Jowell PS: Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med Clins N Am 2000;84:621-631.
6. Zielenski J, Tsui LC: Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995;29:777-807.
7. Etemad, Whitcomb: Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707.
8. Felderbauer P, Hoffmann P, Einwachter H, Bulut K, Ansorge N, Schmitz F, Schmidt WE: A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol 2003;3:34.
9. Schwiebert EM, Benos DJ, Egan ME, Stutts M.T, Guggino WB: CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 1999;79:145-166.
10. Scheele GA, Fukuoka SI, Kern HF, Freedman SD: Pancreatic dysfunction in cystic fibrosis occurs as a result of impairments in luminal pH, apical trafficking of zymogen granule membranes, and solubilization of secretory enzymes. Pancreas 1996;12:1-9.
11. Dork T, Macek MJ, Mekus F, Tummler B, Tzountzouris J, Casals T, Krebsova A, Koudova M, Sakmaryova I, Macek MS, Vavrova V, Zemkova D, Ginter E, Petrova NV, Ivaschenko T, Baranov V, Witt M, Pogorzelski A, Bal J, Zekanowsky C, Wagner K, Stuhrmann M, Bauer I, Seydewitz HH, Neumann T, Jakubiczka S: Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: A cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet 2000;106:259-268.
12. Kiesewetter S, Macek MJ, Davis C, Curristin SM, Chu CS, Graham C, Shrimpton AE, Cashman SM, Tsui LC, Mickle J: A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993;5:274-278.
13. Arduino C, Gallo M, Brusco A, Garnerone S, Piana MR, Di Maggio S, Gerbino PG, Ferrone M, Angeli A, Gaia E: Polyvariant mutant CFTR genes in patients with chronic pancreatitis. Clin Genet 1999;56:400-404.
14. Audrezet MP, Chen JM, Le Marechal C, Ruszniewski P, Robaszkiewicz M, Raguenes O, Quere I, Scotet V, Ferec C: Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2002;10:100-106.
15. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339:653-658.
16. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-652.
17. Dumur V, Gervais R, Rigot JM, Delomel-Vinner E, Decaestecker B, Lafitte JJ, Roussel P: Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): Correlation between genotype and phenotype. Hum Genet 1996;97: 7-10.